In early January 2026, UBS upgraded Bristol-Myers Squibb after highlighting its broad drug pipeline, new clinical trial ...

JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic manufacturing.

In a release, the Ministry of Railways said that while the plan is to double the capacity by 2030, it is expected to be ...

AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board  Seasoned executive with extensive ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Automotive Battery ...

OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ...

Clarivate Plc , a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch report, identifying eleven therapies expected to deliver significant clinical impact ...

Brigham and Women’s Hospital to study the effectiveness and safety of daridorexant for menopause-related insomnia symptoms ...

The Building Controls Industry Association (BCIA) has added exceptional experience to its Management Committee as it ...

The global amyloidosis treatment market is on a trajectory of significant expansion, driven by heightened disease awareness, ...